As a new year begins, I hope that the incoming decision-makers at the Department of Health and Human Services, the Food and Drug Administration, and the Centers for Disease Control will embrace tobacco harm reduction as a public health strategy to be championed, not stymied.
Last year, unfortunately, was one of disappointment. The FDA dealt a dangerous blow to the health of about 37 million adult smokers with burdensome deeming regulations that established its jurisdiction over vaping products. Expensive, time-consuming and often vague, the mandates are poised to endanger the smaller vaping companies that account for much of the innovation in the industry. Already two companies have gone into bankruptcy.